0001179110-15-011227.txt : 20150716 0001179110-15-011227.hdr.sgml : 20150716 20150716162946 ACCESSION NUMBER: 0001179110-15-011227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150714 FILED AS OF DATE: 20150716 DATE AS OF CHANGE: 20150716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quisel John D CENTRAL INDEX KEY: 0001586788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 15991781 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2015-07-14 0 0001280600 ACCELERON PHARMA INC XLRN 0001586788 Quisel John D 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP Gen. Counsel & Secretary Common Stock 2015-07-14 4 M 0 5500 5.88 A 28201 D Common Stock 2015-07-14 4 S 0 5500 30.00 D 22701 D Option to Purchase Common Stock 5.88 2015-07-14 4 M 0 5500 0 D 2019-12-02 Common Stock 5500 4461 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant. /s/ John D. Quisel 2015-07-16